Revvity Expands Its Reach by Acquiring ACD/Labs

Revvity has announced its acquisition of Advanced Chemistry Development, Inc. (ACD/Labs), a significant player in the scientific software industry. This acquisition is poised to enhance Revvity’s scientific software integration capabilities, marking a pivotal step in streamlining innovation and optimizing workflows in the biochemical and pharmaceutical sectors. The collaboration is expected to significantly impact scientific research and development by providing holistic and integrated solutions for their customers.

Revvity, a renowned name in the life sciences market, has been actively expanding its capabilities to include comprehensive software solutions. By acquiring ACD/Labs, a leader known for its advanced analytical and chemical informatics software, Revvity is positioned to better meet the growing demand for integrated solutions in complex scientific environments. ACD/Labs brings a suite of intuitive software solutions designed to support data management, analysis, and reporting, which will be instrumental in enhancing Revvity’s offerings. This acquisition aligns with Revvity’s ongoing mission to drive efficiency and innovation in the life sciences through cutting-edge technology and software solutions.